FDA.reportPublic FDA data

moxidectin 0.24 MG / pyrantel pamoate 50 MG / sarolaner 12 MG Chewable Tablet [Simparica TRIO]

RxCUI
2281743
RxNorm name
moxidectin 0.24 MG / pyrantel pamoate 50 MG / sarolaner 12 MG Chewable Tablet [Simparica TRIO]
Display name
moxidectin 0.24 MG / pyrantel pamoate 50 MG / sarolaner 12 MG Chewable Tablet [Simparica TRIO]
Full name
moxidectin 0.24 MG / pyrantel pamoate 50 MG / sarolaner 12 MG Chewable Tablet [Simparica TRIO]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0f83bcf4-7e89-479f-a980-4cb40456ee78Simparica TRIO 0.24 MG / 50 MG / 12 MG Chewable Tablet [PSN] · moxidectin 0.24 MG / pyrantel pamoate 50 MG / sarolaner 12 MG Chewable Tablet [Simparica TRIO] [SBD] · Simparica TRIO (moxidectin 0.24 MG / pyrantel pamoate 50 MG / sarolaner 12 MG) Chewable Tablet [SY]321Simparica TRIO ®20250523